Premarket Stock Movers — September 14, 2026: Why NCT, BMGL, ELMT, SCNI & VSME Are Surging

NCT — Intercont (Cayman) Ltd (+71.4%)

Intercont (Cayman) Ltd is surging +71.4% to $0.51 in Monday's premarket session, with a stunning 106.7 million shares already changing hands — nearly 28× its 20-day average volume of 3.76 million. For a stock with a total market cap of just $8.0 million, that kind of activity is extraordinary, and it demands extra caution.

Why it's moving: NCT issued an official statement to shareholders on September 10 (via Yahoo Finance) "reinforcing long-term commitment, compliance and transparency," and followed that up with a 6-K filing on September 11. A 6-K is a foreign private issuer's report of a significant event filed with the SEC. Neither disclosure appears to carry hard financial news, but together they appear to have reignited retail attention in the stock. The prior-day after-hours session also saw the name called out in Benzinga's Industrials movers list.

Technical picture heading into today: The daily chart through Friday's close shows NCT carrying a bullish harami candlestick pattern — a two-candle formation where a small green body is nestled inside the prior day's red body, often read as a potential momentum shift. RSI stood at a deeply oversold 21, and the ADX (a measure of trend strength) was at 36, indicating an established directional move. The stock sits 94.3% below its 52-week high, underscoring how beaten-down it has been. The StockSetups conviction score is a low 27/100 (grade D), so the platform's own algorithmic read is skeptical of follow-through.

Float & squeeze read: The free float — the portion of shares actually available for public trading — is just 13.4% of shares outstanding, which means very few shares need to change hands to move the price dramatically. Short interest is minimal (54,926 shares, essentially 0.0 days to cover), so this is not a classical short squeeze. The squeeze score is 47/100. This move looks primarily like a low-float momentum spike on a shareholder-communication catalyst. Stocks like this can reverse violently once premarket liquidity dries up.

BMGL — Basel Medical Group Ltd (+68.4%)

Basel Medical Group is jumping +68.4% to $7.78 premarket, with roughly 9.9 million shares traded versus a 20-day average of just 17,558. That's volume more than 563× the norm — one of the most extreme relative-volume readings you'll see on any given morning. The Healthcare company carries an $86.8 million market cap.

Why it's moving: StocksToTrade and Timothy Sykes' site are both flagging BMGL this morning for a "volatile spike as traders pile in," and Benzinga lists it among the top premarket Healthcare movers. No specific fundamental catalyst — such as an earnings beat, drug approval, or partnership — is on file in today's data. When no hard catalyst is present, moves of this magnitude in low-average-volume names are typically driven by momentum trading: a small number of early orders push the price, which catches the eye of scanning algorithms and retail traders, which draws more orders, compounding the move.

Technical picture heading into today: The daily chart shows a "non signal" lane designation from StockSetups, meaning the stock hadn't yet triggered a confirmed breakout or retest pattern. RSI was a neutral 51 and ADX a soft 17 (weak trend). The MA stack is mixed — some moving averages above price, some below — indicating the stock was in transition rather than a clean uptrend. The stock sits 44.7% below its 52-week high. The conviction score is 57/100 (grade C), giving a modest but not strong technical foundation.

Short squeeze angle: The squeeze score is just 7/100 — low-float plays don't always need short sellers to be squeezed; momentum alone can do the work. Free float is 45.7%, which is more generous than NCT but volume is so extreme that it doesn't much matter. Days to cover (short interest divided by average daily volume) is just 1.3. This is not a squeeze story; it is a pure momentum story. Treat it as such — momentum spikes without a fundamental anchor can evaporate just as fast as they appear.

ELMT — Elmet Group Co. (+43.3%)

Elmet Group is surging +43.3% to $23.20 premarket, on 3.35 million shares — roughly 10× its 20-day average of 336,520. The Industrials company carries a $493.1 million market cap. Of the five movers this morning, ELMT has by far the clearest and most substantive fundamental catalyst.

Why it's moving: Multiple major outlets are reporting this morning that The Elmet Group has secured a $450 million US Government investment to expand the domestic tungsten supply chain, along with a defense contract worth up to $2 billion (Yahoo Finance, Advfn, Stocktwits). Separately, Yahoo Finance also reports that Blue Moon Metals, Elmet, and EQ Resources are committing a combined US$150–175 million to invest in the Springer Tungsten Complex in Nevada. Tungsten is a critical mineral used extensively in defense applications, and US government efforts to onshore its supply chain have been a prominent policy priority. This is a concrete, large-scale government contract announcement — the kind of catalyst that can meaningfully re-rate a company's fair value.

Technical picture heading into today: StockSetups shows ELMT in a "non signal" lane with a conviction score of 0/100 (grade D) heading into today — the algorithm had not flagged a clean setup before the news hit. RSI was a neutral 47, ADX at 23 (moderate trend), and the stock was sitting 26.7% below its 52-week high. Premarket gap is +2.4% on the daily chart basis heading into the open. An 8-K (a material event report) was filed on September 8, which may have foreshadowed a pending announcement.

Short squeeze overlay: The squeeze score is 70/100 — the highest of this morning's group. With 28.6% free float, 4.4 days to cover, and 70% short volume on recent days, there is a meaningful short position in this name. A blockbuster government contract announcement into a heavily shorted, low-float stock is a classic recipe for a squeeze: short sellers may be forced to buy shares to cover losses, adding fuel to an already news-driven rally. Smart money signals are present too — the largest disclosed stake is 8.8%, and two insiders bought shares in April at roughly $14–$20 per share. Those buyers are now sitting on significant paper gains.

SCNI — Scinai Immunotherapeutics Ltd. (+40.8%)

Scinai Immunotherapeutics is up +40.8% to $2.38 premarket, trading 18.7 million shares against a 20-day average of 345,576 — roughly 54× normal volume. The Israeli biotech carries a reported market cap of $23.4 billion, though at a $2.38 stock price that figure warrants scrutiny; it may reflect a large share count or a data anomaly. Healthcare names at this price level with this share count are frequently highly diluted.

Why it's moving: There are no catalyst headlines on file for SCNI this morning. Three 6-K filings (foreign private issuer event reports) were submitted between August 19 and September 8 — all classified as neutral — but none has been linked to a specific announcement driving today's premarket move. With no identifiable catalyst, this move appears to be technically and momentum-driven, likely amplified by the stock's extreme float dynamics.

Float & squeeze read: The free float is a near-impossible 0.1% of shares outstanding. That means virtually no shares are available in the open market relative to total shares outstanding — and at 54× normal volume, the entire tradeable float may already be changing hands multiple times over. The short-volume ratio is 85% — among the highest you'll see — with 70,257 shares short and just 0.1 days to cover. The squeeze score is only 22/100, likely because the tiny short interest means there aren't enough short sellers to generate a classic squeeze; the move is being driven by the vanishingly small float reacting violently to any order flow.

Technical picture heading into today: The daily chart is actually one of the stronger setups in today's group: RSI at 54 (not overbought), ADX at 36 (strong trend), a bullish MA stack (all key moving averages in rising order), a trend-template score of 5, and a conviction score of 67/100 (grade B). The RS rating of 97 means this stock has been outperforming 97% of the market on a relative basis. That said, a 0.1% free float means any technical analysis is compromised by the fact that a handful of trades can move the stock to any price.

VSME — VS MEDIA Holdings Ltd (+25.0%)

VS MEDIA Holdings rounds out this morning's list with a +25.0% gain to $1.30 premarket on 5.44 million shares — about 64× its 20-day average of 84,627. The Communication Services company has a $57.2 million market cap.

Why it's moving: VS MEDIA filed a 6-K (a foreign private issuer event report) on September 11. The filing is classified as a neutral foreign event, with no specific details about its contents provided in the available data. Beyond that filing, no catalyst headline is on file. Like SCNI, this move appears to be primarily momentum-driven, with the 6-K potentially sparking initial retail attention that volume scanners then amplified.

Technical picture heading into today: The daily chart shows a tweezer bottom candlestick — a two-candle pattern where consecutive lows hit approximately the same price level, suggesting buying support has emerged at that level. RSI is 44 (mild oversold lean), ADX is a soft 16 (weak trend), and the MA stack is mixed. The stock is 68.0% below its 52-week high and carries a technical rank of just 25. The conviction score is 47/100 (grade C). The gap heading into today's session on the daily chart is +6.0%, meaning the stock was already showing some life relative to its recent range. The RS rating of 98 indicates strong relative performance versus the broader market.

Short squeeze angle: The free float here is actually large — 90.0% of shares — so this is not a low-float story. Short interest is minimal (25,677 shares, 0.4 days to cover), and the squeeze score is 37/100. The 71% short-volume ratio on recent sessions is notable but, with such low absolute short interest, likely reflects intraday short selling by market makers rather than a buildable squeeze setup. Manage size accordingly.

The bottom line

This morning's five premarket movers span the spectrum from a blockbuster government contract (ELMT's $450M investment + $2B defense deal) to shareholder-communication plays (NCT), pure momentum spikes without an identifiable catalyst (BMGL, SCNI, VSME), and a possible 6-K-triggered retail rush (VSME). What they share: extreme relative volume, small market caps, and the kind of volatility that rewards patience over chasing.

A few important reminders before the 9:30 ET open:

• Premarket prices are not guarantees. Spreads are wide, liquidity is thin, and prices frequently gap down or give back most of the premarket gain once the regular session opens. What looks like +40% at 8 AM can be +15% — or flat — by 10 AM.
• Low-float stocks amplify risk in both directions. The same thin float that lets a stock rocket 70% premarket can let it crater just as fast if sellers show up.
• Momentum without a catalyst is the riskiest trade. BMGL, SCNI, and VSME have no confirmed fundamental driver in today's data. Those moves can evaporate instantly.
• Even strong catalysts don't guarantee follow-through. ELMT's $450M government deal is real and significant — but the stock may have already priced much of that news in by the open.

Always define your risk before entering, size positions accordingly, and do your own research. This recap is educational only — not financial advice or a recommendation to buy or sell any security.

StockSetups scans the full ~12,300-stock US universe every premarket morning, detecting chart patterns confirmed by candlesticks and surfacing the setups with the strongest conviction scores, squeeze setups, and smart-money signals — so you have a structured framework ready before the open bell. Check back after today's close for the full after-hours recap.

For more context on this week's premarket action, see Friday's Premarket Stock Movers — September 11, 2026 and the Top Stock Movers recap for September 11.